12/15
07:05 am
fgen
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration [Yahoo! Finance]
Low
Report
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration [Yahoo! Finance]
12/15
07:00 am
fgen
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration
Medium
Report
Roxadustat Granted Orphan Drug Designation for the Treatment of Myelodysplastic Syndromes by the U.S. Food and Drug Administration
12/2
07:07 pm
fgen
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit [Yahoo! Finance]
Low
Report
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit [Yahoo! Finance]
12/2
04:05 pm
fgen
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit
Low
Report
FibroGen to Present at the Oppenheimer Movers in Rare Disease Summit
11/11
12:30 am
fgen
FibroGen Inc (FGEN) Q3 2025 Earnings Call Highlights: Strategic Moves Bolster Financial ... [Yahoo! Finance]
High
Report
FibroGen Inc (FGEN) Q3 2025 Earnings Call Highlights: Strategic Moves Bolster Financial ... [Yahoo! Finance]
11/10
10:02 pm
fgen
FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
FibroGen, Inc. (FGEN) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/10
04:32 pm
fgen
FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
High
Report
FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update [Yahoo! Finance]
11/10
04:02 pm
fgen
FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update
Medium
Report
FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update
11/3
04:02 pm
fgen
FibroGen to Report Third Quarter 2025 Financial Results
Low
Report
FibroGen to Report Third Quarter 2025 Financial Results
10/7
07:36 am
fgen
Progentos Therapeutics Names Paul Frohna Chief Medical Officer [Yahoo! Finance]
Medium
Report
Progentos Therapeutics Names Paul Frohna Chief Medical Officer [Yahoo! Finance]